DIP2C has been shown to regulate DNA methylation and the epithelial–mesenchymal transition in human cell lines (Larsson et al., 2017), and mutations in DIP2C have been associated with skeletal dysplasia affecting bone and cartilage development in humans (Maddirevula et al., 2018). The gene discussed is DIP2C; the disease is skeletal dysplasia.